Elekta's Esteya electronic brachytherapy improves outcomes in patients with basal cell carcinoma

Physicians at La Fe University and Polytechnic Hospital - Valencia presented their early clinical outcome data on the use of Esteya® electronic brachytherapy for the treatment of basal cell carcinoma in a paper in the current issue of Journal of Contemporary Brachytherapy. The ongoing study showed 100 percent complete response and excellent cosmetic outcome in all lesions treated to date with Esteya.

The paper, "Efficacy and safety of electronic brachytherapy for superficial and nodular basal cell carcinoma," is based on data from an ongoing, prospective clinical study.

The investigators conclude that Esteya electronic brachytherapy is a good treatment alternative for patients who are unsuitable for surgery, in addition to those who have declined surgery, have multiple lesions and for whom electronic brachytherapy might improve cosmetic outcome.

SOURCE Elekta

Posted in: Device / Technology News | Medical Research News | Medical Condition News

Tags: , , , , , , , , , , , , , , ,

Comments (0)

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Elekta. (2023, September 12). Elekta's Esteya electronic brachytherapy improves outcomes in patients with basal cell carcinoma. News-Medical. Retrieved on September 26, 2023 from https://www.news-medical.net/news/20150617/Elektas-Esteya-electronic-brachytherapy-improves-outcomes-in-patients-with-basal-cell-carcinoma.aspx.

  • MLA

    Elekta. "Elekta's Esteya electronic brachytherapy improves outcomes in patients with basal cell carcinoma". News-Medical. 26 September 2023. <https://www.news-medical.net/news/20150617/Elektas-Esteya-electronic-brachytherapy-improves-outcomes-in-patients-with-basal-cell-carcinoma.aspx>.

  • Chicago

    Elekta. "Elekta's Esteya electronic brachytherapy improves outcomes in patients with basal cell carcinoma". News-Medical. https://www.news-medical.net/news/20150617/Elektas-Esteya-electronic-brachytherapy-improves-outcomes-in-patients-with-basal-cell-carcinoma.aspx. (accessed September 26, 2023).

  • Harvard

    Elekta. 2023. Elekta's Esteya electronic brachytherapy improves outcomes in patients with basal cell carcinoma. News-Medical, viewed 26 September 2023, https://www.news-medical.net/news/20150617/Elektas-Esteya-electronic-brachytherapy-improves-outcomes-in-patients-with-basal-cell-carcinoma.aspx.

Suggested Reading

Brainlab unveils ExacTrac Dynamic at ASTRO meeting in San Antonio, Texas
Elekta introduces new Leksell Gamma Knife Icon to treat patients with brain disease
Elekta and the International Atomic Energy Agency (IAEA) partner to improve access to cancer care in underserved countries
Spinal cord stimulation may help reduce chronic pain in people undergoing active cancer treatment
Elekta striving to build radiation therapy infrastructures and save lives of cancer patients in Africa
Elekta inks contract with Samsung Medical Center to provide the first Leksell Gamma Knife Icon to Asia
Elekta updates latest R&D work with special focus on high field MRI-guided radiation therapy
Three European medical centers planning upgrades to Elekta's stereotactic radiosurgery system for the brain

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »
You might also like...
New PULSAR radiation-therapy strategy achieves better tumor control